Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13045-015-0195-4
Published Online: 2015-09-04
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Wu, Jingjing
Fu, Jiaping
Zhang, Mingzhi
Liu, Delong
Funding for this research was provided by:
National Natural Science Foundation of China (CN) (81201793)